← Evidence map

ReviewOncology reports2026

HMGB3: A pivotal orchestrator of therapy resistance and cancer stemness in human malignancies (Review).

Ju Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 41930588